The Effect of TECAR Therapy on Pain and Shoulder Function in Patients With Rotator Cuff Tendinopathy
1 other identifier
interventional
36
1 country
1
Brief Summary
Shoulder pain is one of the most common symptoms of musculoskeletal injuries; one-quarter of the general population and two-thirds of adults experience this problem at some point in their lives.Rotator cuff tendinopathy also presents as a significant socio-economic issue, affecting patients' functionality, sleep, quality of life, and work performance. TECAR therapy (Targeted Radiofrequency Therapy) is a relatively new physical therapy method. This technique aims to induce hyperthermia in deep tissues by transferring high-frequency electromagnetic energy via capacitive-resistive electric transfer (CRET). This study aims to directly compare TECAR-a relatively new treatment modality-with exercise, which is crucial in shoulder rehabilitation, by evaluating the effects of both treatments on pain reduction, shoulder function, and quality of life in patients with rotator cuff tendinopathy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2026
CompletedFirst Posted
Study publicly available on registry
September 17, 2026
CompletedStudy Start
First participant enrolled
September 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 18, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
September 22, 2026
September 1, 2026
1 month
September 11, 2026
September 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analogue Scale (VAS)
Visual Analog Scale (VAS): Pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 ("no pain") to 10 ("worst pain imaginable"). Participants will mark the point on the scale that best represents their perceived pain intensity at the time of assessment. Higher scores indicate greater pain intensity.
Baseline (T0)Week 2 (T1): At the end of the first group treatmentPost-treatment (T2): Immediately after completion of the treatment program
Secondary Outcomes (4)
Shoulder joint range of motion measurements
Baseline (T0)Week 2 (T1): At the end of the first group treatmentPost-treatment (T2): Immediately after completion of the treatment program
Western Ontario Rotator Cuff Index
Baseline (T0)Week 2 (T1): At the end of the first group treatmentPost-treatment (T2): Immediately after completion of the treatment program
Shoulder Pain and Disabilty Index
Baseline (T0)Week 2 (T1): At the end of the first group treatmentPost-treatment (T2): Immediately after completion of the treatment program
Nottingham Health Profile (NHP)
Baseline (T0)Week 2 (T1): At the end of the first group treatmentPost-treatment (T2): Immediately after completion of the treatment program
Study Arms (2)
Physical Therapy Group
ACTIVE COMPARATORA total of 10 treatment sessions-consisting of 5 sessions per week-will be administered, comprising a shoulder exercise program that includes range-of-motion exercises, stretching exercises (targeting the posterior joint capsule and pectoral muscles), rotator cuff strengthening exercises, and scapular mobilization exercises.
TECAR Group
ACTIVE COMPARATORIn addition to exercise, TECAR therapy will be administered for a total of 10 sessions-at a frequency of 448 kHz and a duration of 25 minutes per session (10 minutes in capacitive mode and 15 minutes in resistive mode)-with a frequency of 5 sessions per week.
Interventions
A shoulder exercise program-comprising range-of-motion exercises, stretching exercises (including the posterior joint capsule and pectoral muscles), rotator cuff strengthening exercises, and scapular mobilization exercises-will be administered over a total of 10 sessions, at a frequency of 5 sessions per week. In addition to the exercises, TECAR therapy will be administered over a total of 10 sessions (5 sessions per week), consisting of a total duration of 25 minutes (10 minutes in capacitive mode and 15 minutes in resistive mode at a frequency of 448 kHz).
A total of 10 treatment sessions-consisting of 5 sessions per week-will be administered, comprising a shoulder exercise program that includes range-of-motion exercises, stretching exercises (targeting the posterior joint capsule and pectoral muscles), rotator cuff strengthening exercises, and scapular mobilization exercises.
Eligibility Criteria
You may qualify if:
- Individuals experiencing pain in the shoulder and/or lateral deltoid region, with pain exacerbation during overhead activities.
- Individuals exhibiting tenderness upon palpation at the rotator cuff tendon insertion site on the proximal humerus and/or restricted range of motion during active shoulder flexion, abduction, and internal and external rotation upon physical examination.
- Individuals diagnosed with rotator cuff tendinosis or a partial-thickness tendon tear via imaging methods (ultrasound, magnetic resonance imaging).
You may not qualify if:
- Full-thickness rotator cuff tear
- Previous shoulder surgery
- Presence of other conditions capable of causing shoulder pain and loss of function (other joint pathologies, cervical radiculopathy, etc.)
- Systemic diseases such as diabetes, rheumatoid arthritis, hepatitis, or coagulopathy
- Pregnancy
- Infection
- Pacemaker
- Peripheral circulatory disorder
- Known concomitant malignancy or end-stage organ failure
- Intra-articular/subacromial steroid injection within the last 6 weeks or NSAID treatment within the last week.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ayşe Ukbe Baykutlead
- Ankara Bilkent Sehir Hastanesicollaborator
Study Sites (1)
Bilkent City Hospital
Ankara, Ankara, 06800, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayşe U BAYKUT
Ankara City Hospital Bilkent
Central Study Contacts
kerem Çekinel
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 11, 2026
First Posted
September 17, 2026
Study Start
September 18, 2026
Primary Completion (Estimated)
October 18, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
September 22, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
I haven't been able to decide yet.